Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents-Reference-Cited by-同舟云学术

Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Published:2021-12 Issue: Volume: Page:
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mahtani Reshma^ORCID,Oestreicher Nina,Lalla Deepa,Ogbonnaya Augustina,Saundankar Vishal^ORCID,Willey Joanne,Coutinho Anna D.,McCann Kelly^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Medical care costs associated with cancer survivorship in the United States;Mariotto;Cancer Epidemiol Biomarkers Prev,2020

2. National Institutes of Health (NIH) National Cancer Institute (NCI). Cancer prevalence and cost of care projections. Updated 2020. Accessed February 13, 2021. Available at: https://costprojections.cancer.gov.

3. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

4. Projections of the cost of cancer care in the United States: 2010–2020;Mariotto;J Natl Cancer Inst,2011

5. National Cancer Institute. SEER Cancer stat facts: female breast cancer subtypes. Accessed February 12, 2021. Available at: https://seer.cancer.gov/statfacts/html/breast-subtypes.html

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review;Advances in Therapy;2024-06-04

2. Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer;Therapeutic Advances in Medical Oncology;2023-01